Views & Analysis Bad behaviour: why understanding human behaviour can improve... Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.
Views & Analysis Behaviour science: the new capability every pharma company s... Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.
Views & Analysis How behavioural science is helping in the fight against COVI... Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of changing how we live.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.